References
- DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23
- Toffolo G, De Grandi F, Cobelli C. Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion. Diabetes 1995;44:845-54
- Bergman RN, Ider YZ, Bowden CR, et al. Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-77
- Breda E, Cavaghan MK, Toffolo G, et al. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 2001;50:150-8
- Dalla Man C, Caumo A, Cobelli C. The oral glucose minimal model: estimation of insulin sensitivity from a meal test. IEEE Trans Biomed Eng 2002;49:419-29
- Agbaje OF, Luzio SD, Albarrak AI, et al. Bayesian hierarchical approach to estimate insulin sensitivity by minimal model. Clin Sci (Lond) 2003;105:551-60
- Vicini P, Cobelli C. The iterative two-stage population approach to IVGTT minimal modeling: improved precision with reduced sampling. Intravenous glucose tolerance test. Am J Physiol Endocrinol Metab 2001;280:E179-86
- Whiting B, Kelman AW, Grevel J. Population pharmacokinetics. Theory and clinical application. Clin Pharmacokinet 1986;11:387-401
- Beal SL, Sheiner LB. Estimating population kinetics. Crit Rev Biomed Eng 1982;8:195-222
- De Gaetano A, Mingrone G, Castageneto M. NONMEM improves group parameter estimation for the minimal model of glucose kinetics. Am J Physiol 1996;271:E932-7
- Expert Committee on the Diagnosis and Classification of Diabetes. American Diabetes Association Clinical Practice recommendations. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27:S5-S10
- Bruce DG, Chisholm DJ, Storlien LH, et al. Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes 1988;37:736-44
- Matthews DR, Hosker JP, Rudensk, AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19
- Theodorakis MJ, Carlson O, Muller DC, et al. Elevated plasma glucose-dependent insulinotropic polypeptide (GIP) associates with hyperinsulinemia in impaired glucose tolerance. Diabetes Care 2004;27:1692-8
- Kjems LL, Christiansen E, Volund A, et al. Validation of methods for measurement of insulin secretion in humans in vivo. Diabetes 2000;49:580-8
- Watanabe RM, Steil GM, Bergman RN. Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion. Am J Physiol 1998;274:E172-83
- Barrett PH, Bell BM, Cobelli C, et al. SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. Metabolism 1998;47:484-92
- Beal SL, Sheiner LB. NONMEM User Guide. San Francisco, CA: NONMEM Project Group, Univ. of California San Francisco, 1992
- Davidian M, Giltinan D. Nonlinear Models for Repeated Measurement Data. New York: Chapman and Hall, 1995
- Wagenknecht LE, Mayer EJ, Rewers M, et al. The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 1995;5:464-72
- Unwin N, Shaw J, Zimmet P, et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19:708-23
- Elahi D, Muller DC, McAloon-Dyke M, et al. The effect of age on insulin response and glucose utilization during four hyperglycemic plateaus. Exp Gerontol 1993;28:393-409
- Rostami-Hodjegan A, Peacey SR, George E, et al. Population-based modeling to demonstrate extrapancreatic effects of tolbutamide. Am J Physiol 1998;274:E758-71
- Valle T, Tuomilehto J, Bergman RN, et al. Mapping genes for NIDDM. Design of the Finland–United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care 1998;21:949-58
- Schirra J, Katschinski M, Weidmann C, et al. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 1996;97:92-103
- Toffolo G, Breda E, Cavaghan MK, et al. Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models. Am J Physiol Endocrinol Metab 2001;280:E2-10
- Finegood DT, Tzur D. Reduced glucose effectiveness associated with reduced insulin release: an artifact of the minimal-model method. Am J Physiol 1996;271:E485-95
- Van Cauter E, Mestrez F, Sturis J, et al. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 1992;41:368-77